A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2018
At a glance
- Drugs Nomacopan (Primary)
- Indications Atypical Haemolytic Uraemic Syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Akari Therapeutics
- 21 Mar 2018 According to an Akari Therapeutics media release, this trial was initiated in fourth quarter of 2017.
- 06 Feb 2018 Status changed from planning to recruiting, according to an Akari Therapeutics media release.
- 27 Apr 2017 New trial record